Alternus Clean Energy (ALCED) vs. Its Peers Head to Head Survey

Insider & Institutional Ownership

35.3% of shares of all “Independent Power & Renewable Electricity Producers” companies are held by institutional investors. 44.1% of Alternus Clean Energy shares are held by insiders. Comparatively, 21.7% of shares of all “Independent Power & Renewable Electricity Producers” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Alternus Clean Energy and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Alternus Clean Energy	$310,000.00	$21.08 million	-0.00
Alternus Clean Energy Competitors	$6.35 billion	$832.74 million	13.07

Alternus Clean Energy’s peers have higher revenue and earnings than Alternus Clean Energy. Alternus Clean Energy is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Alternus Clean Energy and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alternus Clean Energy	N/A	N/A	-40.51%
Alternus Clean Energy Competitors	-42.28%	13.57%	0.81%

Risk & Volatility

Alternus Clean Energy has a beta of -1.13, indicating that its share price is 213% less volatile than the S&P 500. Comparatively, Alternus Clean Energy’s peers have a beta of -66.39, indicating that their average share price is 6,739% less volatile than the S&P 500.

Summary

Alternus Clean Energy peers beat Alternus Clean Energy on 6 of the 9 factors compared.

Alternus Clean Energy Company Profile

Alternus Clean Energy, Inc. operates as a power producer. It develops, installs, owns and operates utility scale solar parks in America and Europe. It operates through the United States and Europe geographical segments. The company was founded by Vincent Browne in 2017 and is headquartered in New York, NY.